Aclaris Therapeutics, Inc. (NASDAQ: ACRS) has announced significant findings about ATI-2138, a novel investigational drug ...

Researchers have pointed out on the limited data on the research and have suggested to continue using the three approved ...

The blockbuster drug semaglutide, better known as Ozempic for diabetes and Wegovy for obesity, could also help people cut down on their alcohol intake, according to new USC research.

A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.

SGLT-2 inhibitors and GLP-1 receptor agonists are linked to a reduced risk of COPD exacerbations in patients with type 2 ...

For years, people taking Ozempic or other drugs in the same class for diabetes and weight loss have noticed the medicines don ...

A new study suggests that semaglutide, a drug commonly used for diabetes and obesity, may also help reduce alcohol consumption.

Many people claim that cannabidiol (CBD) helps them manage their anxiety. In recent years, CBD has been widely studied for its potential benefits to help with numerous conditions, including ...

In the first years following a diagnosis, survival rates are lower, compared to hormone receptor-positive cancers, but, unlike hormonal receptor-positive tumors—which are notorious for having late ...

Tumor necrosis factor receptor 1 (TNFR1) is a single-spanning type I transmembrane protein with several cysteine-rich extracellular domains, and also known as one of the major receptors of TNFα. Due ...

They’re also called serotonin receptor agonists. Serotonin is a neurotransmitter that nerve cells produce. It’s found in different nerves all over the body, including the brain. While the ...

“In terms of the list of conditions and/ or symptoms that are reported to be increased by GLP1 receptor agonists, as expected gastrointestinal upset of various kinds is most common adverse effect. The ...